PhotoniCare Achieves More Than $7 Million in Funding for Commercial Expansion of First-In-Class Ear Imaging Technology

PhotoniCare, in January of this year, announced that the U.S. Food and Drug Administration had granted clearance for its TOMi™ Scope for non-invasive imaging of the middle ear.